Annual Current Liabilities
$2.79 M
+$618.00 K+28.51%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual total current liabilities is $2.79 million, with the most recent change of +$618.00 thousand (+28.51%) on December 31, 2023.
- During the last 3 years, DMAC annual current liabilities has risen by +$758.00 thousand (+37.38%).
- DMAC annual current liabilities is now at all-time high.
Performance
DMAC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.30 M
+$1.21 M+39.15%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly total current liabilities is $4.30 million, with the most recent change of +$1.21 million (+39.15%) on September 30, 2024.
- Over the past year, DMAC quarterly current liabilities has increased by +$2.13 million (+98.02%).
- DMAC quarterly current liabilities is now at all-time high.
Performance
DMAC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
DMAC Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +28.5% | +98.0% |
3 y3 years | +37.4% | +164.6% |
5 y5 years | +115.0% | +164.6% |
DMAC Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +82.8% | at high | +199.7% |
5 y | 5-year | at high | +111.4% | at high | +359.6% |
alltime | all time | at high | +5127.0% | at high | +7961.9% |
DiaMedica Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.30 M(+39.2%) |
Jun 2024 | - | $3.09 M(+18.0%) |
Mar 2024 | - | $2.62 M(-6.1%) |
Dec 2023 | $2.79 M(+28.5%) | $2.79 M(+28.4%) |
Sep 2023 | - | $2.17 M(+11.5%) |
Jun 2023 | - | $1.95 M(-30.8%) |
Mar 2023 | - | $2.81 M(+29.8%) |
Dec 2022 | $2.17 M(+42.3%) | $2.17 M(+40.6%) |
Sep 2022 | - | $1.54 M(+0.4%) |
Jun 2022 | - | $1.54 M(+7.1%) |
Mar 2022 | - | $1.43 M(-5.9%) |
Dec 2021 | $1.52 M(-24.9%) | $1.52 M(-6.2%) |
Sep 2021 | - | $1.62 M(+12.8%) |
Jun 2021 | - | $1.44 M(+22.2%) |
Mar 2021 | - | $1.18 M(-41.9%) |
Dec 2020 | $2.03 M(+53.9%) | $2.03 M(+40.5%) |
Sep 2020 | - | $1.44 M(+18.6%) |
Jun 2020 | - | $1.22 M(+30.2%) |
Mar 2020 | - | $935.00 K(-29.1%) |
Dec 2019 | $1.32 M(+1.7%) | $1.32 M(+9.4%) |
Sep 2019 | - | $1.21 M(+27.2%) |
Jun 2019 | - | $947.00 K(-33.5%) |
Mar 2019 | - | $1.43 M(+10.0%) |
Dec 2018 | $1.30 M(+29.2%) | $1.30 M(-11.2%) |
Sep 2018 | - | $1.46 M(+17.8%) |
Jun 2018 | - | $1.24 M(+12.0%) |
Mar 2018 | - | $1.11 M(+10.2%) |
Dec 2017 | $1.00 M(+31.3%) | $1.00 M(+48.6%) |
Sep 2017 | - | $674.80 K(-33.8%) |
Jun 2017 | - | $1.02 M(-4.3%) |
Mar 2017 | - | $1.06 M(+39.3%) |
Dec 2016 | $764.00 K(-28.4%) | $764.00 K(-48.9%) |
Sep 2016 | - | $1.50 M(+1.7%) |
Jun 2016 | - | $1.47 M(+49.1%) |
Mar 2016 | - | $986.70 K(-7.5%) |
Dec 2015 | $1.07 M | $1.07 M(+20.1%) |
Sep 2015 | - | $887.90 K(+51.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $584.70 K(-13.3%) |
Mar 2015 | - | $674.20 K(-62.8%) |
Dec 2014 | $1.81 M(+18.8%) | $1.81 M(+28.7%) |
Sep 2014 | - | $1.41 M(-14.0%) |
Jun 2014 | - | $1.64 M(-28.2%) |
Mar 2014 | - | $2.28 M(+49.5%) |
Dec 2013 | $1.52 M(-3.7%) | $1.52 M(+58.3%) |
Sep 2013 | - | $962.80 K(+6.4%) |
Jun 2013 | - | $904.80 K(-46.4%) |
Mar 2013 | - | $1.69 M(+6.7%) |
Dec 2012 | $1.58 M(+334.0%) | $1.58 M(+92.9%) |
Sep 2012 | - | $820.20 K(-12.2%) |
Jun 2012 | - | $934.50 K(+23.6%) |
Mar 2012 | - | $756.00 K(+107.4%) |
Dec 2011 | $364.60 K(-34.2%) | $364.60 K(-23.2%) |
Sep 2011 | - | $474.70 K(-11.6%) |
Jun 2011 | - | $536.70 K(-2.9%) |
Mar 2011 | - | $553.00 K(-0.2%) |
Dec 2010 | $554.10 K(+180.0%) | $554.10 K(+219.0%) |
Sep 2010 | - | $173.70 K(-85.6%) |
Jun 2010 | - | $1.21 M(+118.6%) |
Mar 2010 | - | $553.00 K(+179.4%) |
Dec 2009 | $197.90 K(-9.2%) | $197.90 K(+10.8%) |
Sep 2009 | - | $178.60 K(+202.2%) |
Jun 2009 | - | $59.10 K(-77.3%) |
Mar 2009 | - | $260.10 K(+19.3%) |
Dec 2008 | $218.00 K(-20.0%) | $218.00 K(-12.4%) |
Sep 2008 | - | $248.80 K(-24.9%) |
Jun 2008 | - | $331.40 K(+9.5%) |
Mar 2008 | - | $302.70 K(+11.1%) |
Dec 2007 | $272.40 K(+411.1%) | $272.40 K(+166.0%) |
Sep 2007 | - | $102.40 K(-74.0%) |
Jun 2007 | - | $393.60 K(+155.3%) |
Mar 2007 | - | $154.20 K(+189.3%) |
Dec 2006 | $53.30 K(-5.7%) | $53.30 K(-10.0%) |
Sep 2006 | - | $59.20 K(+4.8%) |
Dec 2005 | $56.50 K(-95.6%) | $56.50 K |
Dec 2004 | $1.28 M | - |
FAQ
- What is DiaMedica Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual current liabilities year-on-year change?
- What is DiaMedica Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly current liabilities year-on-year change?
What is DiaMedica Therapeutics annual total current liabilities?
The current annual current liabilities of DMAC is $2.79 M
What is the all time high annual current liabilities for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual total current liabilities is $2.79 M
What is DiaMedica Therapeutics annual current liabilities year-on-year change?
Over the past year, DMAC annual total current liabilities has changed by +$618.00 K (+28.51%)
What is DiaMedica Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of DMAC is $4.30 M
What is the all time high quarterly current liabilities for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly total current liabilities is $4.30 M
What is DiaMedica Therapeutics quarterly current liabilities year-on-year change?
Over the past year, DMAC quarterly total current liabilities has changed by +$2.13 M (+98.02%)